Valeritas Announces $150 Million Financing 09/12/2011
Valeritas Receives European CE Mark Approval for the V-Go™ Disposable Insulin Delivery Device 07/25/2011
Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog® 03/01/2011
Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device 12/08/2010
Valeritas Announces Appointment of New CFO - Former Amicus Therapeutics Chief Financial Officer James E. Dentzer Joins Executive Team 03/17/2010
Valeritas Announces Appointment of New CEO - Former Johnson & Johnson Executive Kristine Peterson to Take Helm 06/01/2009
